1. Obesity-associated variants within FTO form long-range functional connections with IRX3
- Author
-
Smemo, Scott, Tena, Juan J., Kim, Kyoung-Han, Gamazon, Eric R., Sakabe, Noboru J., Gomez-Marin, Carlos, Aneas, Ivy, Credidio, Flavia L., Sobreira, Debora R., Wasserman, Nora F., Lee, Ju Hee, Puviindran, Vijitha, Tam, Davis, Shen, Michael, Son, Joe Eun, Vakili, Niki Alizadeh, Sung, Hoon-Ki, Naranjo, Silvia, Acemel, Rafael D., Manzanares, Miguel, Nagy, Andras, Cox, Nancy J., Hui, Chi-Chung, Gomez-Skarmeta, Jose Luis, and Nobrega, Marcelo A.
- Subjects
Homeobox genes -- Properties ,Obesity -- Genetic aspects ,Genomics ,Gene expression ,Body weight -- Genetic aspects ,Homeotic genes -- Properties ,Single nucleotide polymorphisms ,Genome-wide association studies ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type 2 diabetes (T2D) (1-3). Although the molecular mechanisms linking these noncoding variants with obesity are not immediately obvious, subsequent studies in mice demonstrated that FTO expression levels influence body mass and composition phenotypes (4-6). However, no direct connection between the obesity-associated variants and FTO expression or function has been made (7-9). Here we show that the obesity-associated noncoding sequences within FTO are functionally connected, at megabase distances, with the homeobox gene IRX3. The obesity-associated FTO region directly interacts with the promoters of IRX3 as well as FTO in the human, mouse and zebrafish genomes. Furthermore, long-range enhancers within this region recapitulate aspects of IRX3 expression, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3. Consistent with this, obesity-associated single nucleotide polymorphisms are associated with expression of IRX3, but not FTO, in human brains. A direct link between IRX3expression and regulation of body mass and composition is demonstrated by a reduction in body weight of 25 to 30% in Irx3-deficient mice, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue. Finally, hypothalamic expression of a dominant-negative form of Irx3 reproduces the metabolic phenotypes of Irx3-deficient mice. Our data suggest that IRX3is a functional long-range target of obesity-associated variants within FTO and represents a novel determinant of body mass and composition., Noncoding variation in single nucleotide polymorphisms (SNPs) within a 47-kilobase (kb) region of high linkage disequilibrium in introns 1 and 2 of FTO remains the strongest genetic association with risk [...]
- Published
- 2014